Alan Crane - Profile and Investment Details

Investor Profile

Alan Crane is a Venture Capital based in United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize, Cardurion Pharmaceuticals, NetRate Systems, Recurly, Armorblox, Amagma Therapeutics, FOLX Health, Kallyope, Vico Therapeutics, Faraday Pharmaceuticals, AgBiome, Metacrine, Cerulean Pharma, OM1, Hydra Biosciences, Alector, B2Gnow, Freenome, Mesodyne, Morphic Therapeutic, Adagio Therapeutics, Pandion Therapeutics, Montis Biosciences, Adimab, Candesant Biomedical, ByHeart, Simon Data, Covetrus, T2 Biosystems, Ocular Therapeutix, Seismic Therapeutic, Cyclerion Therapeutics, KenSci, Neogene Therapeutics, Lyra Therapeutics, Sesh, Africa Healthcare Network, Gauss Surgical, EGenesis, Wellthy, Tectonic Therapeutic, TARIS Biomedical, Profitero, Automotive Titling Company, Iora Health, ClearSky Data, BlackThorn Therapeutics, Keeps, Scholar Rock, Dewpoint Therapeutics, Foresight Mental Health, Caledonia Spirits, Sonrai Security, Auron Therapeutics, Volastra Therapeutics, Navitor Pharmaceuticals, YourBio Health, Ankyra, Quentis Therapeutics, Drizly, Amunix, Ajax Health, Kronos Bio, FidoCure, SQZ Biotech, Twistlock, Gossamer Bio, Thirty Madison, Dyno Therapeutics, Primmune Therapeutics, Pointy, Lyndra Therapeutics, FloQast, Jnana, SpineZone, Podimetrics, CAMP4 Therapeutics, IconOVir Bio, 1366 Technologies, Falkonry, Tausight, Nomad Health, Allstacks. Over time, Alan Crane has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alan Crane is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Medical Testing, Women Led, Artificial Intelligence (AI), Information Technology (IT), Biotech, Software, Healthcare, Biotechnology, Neuroscience, Health Diagnostics, Medical, Therapeutics, Machine Learning, Developer Platform, Pharmaceuticals may find it worthwhile to explore potential connections with Alan Crane, as their portfolio suggests a familiarity and interest in this area.

Understanding Alan Crane’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.